Introduction
Identification of Campylobacter spp. is traditionally performed by isolation of the organism and the determination of its gram-staining, cultural and biochemical characteristics. However, these phenotypic methods of bacterial identification have two major drawbacks when they are used for Campylobacter speciation. First, some phenotypic characteristics are frequently found to be variable in different Campylobacter species. A small percentage of C. fetus are able to grow at 428C, some C. jejuni strains are hippurate negative and an increasing percentage of C. jejuni strains are resistant to nalidixic acid [1] [2] [3] . Second, some characteristics such as production of alkaline phosphatase and growth in glycine 1%, NaCl 1.5% and NaCl 3.5% are highly dependent on the inoculum size and the medium used, and the results of such tests are difficult to interpret [4] [5] [6] . Therefore, these tests are usually not performed in most clinical microbiology laboratories.
Since the discovery of the polymerase chain reaction (PCR) and DNA sequencing, comparison of the gene sequences of bacterial species has shown that the 16S ribosomal (r) RNA gene is highly conserved within a species and among species of the same genus, and hence can be used as the new gold standard for speciation of bacteria. Utilising this principle, bacteria are classified and re-classified into new genera [7, 8] , and the genus Campylobacter is now classified into 16 different species. Furthermore, bacteria with ambiguous identity because of unusual biochemical profiles can be identified [9] . Recently, the use of this technique has been reported for the identification of bacterial strains with ambiguous biochemical profiles [10] [11] [12] [13] , species that are rarely encountered clinically [14] [15] [16] and a bacterium that cannot be cultured [17] , discovery of a novel clinical syndrome [18] and two novel species [19, 20] and characterisation of â-haemolytic Lancefield group G streptococcal bacteraemia [21] .
This report describes the application of 16S rRNA gene sequencing in the identification to Campylobacter isolates from the blood cultures of eight immunocompromised patients.
Materials and methods

Patients, bacterial isolates and microbiological methods
The eight patients in this study were hospitalised at the Queen Mary Hospital in Hong Kong during 1996-2000. All clinical data were collected prospectively as described previously [22] . The BACTEC 9240 blood culture system (Becton Dickinson, MD, USA) was used. All blood culture isolates were identified by standard conventional biochemical methods with C. fetus subsp. fetus (ATCC 27374), C. fetus subsp. venerealis (ATCC 19438) and C. jejuni subsp. jejuni (ATCC 33560) as the control strains [5, 6, 23] and the phenotypic characteristics were compared to those of the known Campylobacter species [24] [25] [26] [27] [28] [29] . All tests were performed with freshly prepared media on three separate occasions. The MICs of ampicillin, clarithromycin, gentamicin, ciprofloxacin and imipenem were determined by the macrobroth dilution method with Mueller-Hinton broth [30] . The cultures were incubated at 378C under micro-aerobic conditions. Bacterial growth was examined at 24 h.
Extraction of bacterial DNA for 16S rRNA gene sequencing
Bacterial DNA extraction was modified from a previously published protocol [31] . Briefly, 80 ìl of 0.05 M NaOH were added to 20 ìl of bacterial cells suspended in distilled water and the mixture was incubated at 608C for 45 min, followed by addition of 6 ìl of 1 M Tris-HCl (pH 7.0) to give a final pH of 8.0. The resultant mixture was diluted 1 in 100 and 5 ìl of the diluted extract were used for PCR.
PCR, gel electrophoresis and 16S rRNA gene sequencing PCR amplification and DNA sequencing of the 16S rRNA gene were performed as described previously [32] . Briefly, distilled water and the PCR master mix containing deoxynucleoside triphosphates (dNTPs), PCR buffer and Taq polymerase were first treated by adding 1 U of DNAase I (Pharmacia, Sweden) to 40 ìl of distilled water or PCR master mix, incubating the mixture at 258C for 15 min, and subsequently at 958C for 10 min to inactivate the DNAase I. The bacterial DNA extract and control were amplified with 0.5 ìM primers (LPW57 59-AGTTTGATCCTGGCTCAG-39 and LPW182 59-AGTCGCTGATTCCACTGTGG-39) (Gibco BRL, Rockville, MD, USA). The PCR mixture (50 ìl) contained bacterial DNA, PCR buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 2 mM MgCl 2 and gelatin 0.01%), 200 ìM of each dNTP and Taq polymerase (Boehringer Mannheim, Germany) 1.0 U. The mixtures were amplified for 40 cycles of 948C for 1 min, 558C for 1 min and 728C for 2 min, and a final extension at 728C for 10 min in an automated thermal cycler (Perkin-Elmer Cetus, Gouda, The Netherlands). DNAase I-treated distilled water was used as the negative control. Ten ìl of each amplified reaction product, together with molecular size markers (º DNA AvaI digest, Boehringer Mannheim) were electrophoresed in agarose 1.0% w/v gel in Tris-borate-EDTA buffer at 100 V for 1.5 h. The gel was stained with ethidium bromide 0:5 ìg=ml for 15 min, rinsed and photographed under UV light.
The PCR product was gel-purified with the QIAquick PCR purification kit (Qiagen, Hilden, Germany). Both strands of the PCR product were sequenced twice with an ABI 310 automated sequencer according to the manufacturer's instructions (Perkin-Elmer, Foster City, CA, USA), with the PCR primers (LPW57 and LPW182) and additional primers designed from the sequencing data of the first round of sequencing reaction (LPW69 59-AGCACCGGCTAACTCCGT-39 and LPW232 59-AGTTTTAATCTTGCGA-39). The sequence of the PCR product was compared with known 16S rRNA gene sequences in the GenBank database by multiple sequence alignment with the CLUSTAL W programme [33] . The phylogenetic tree was constructed by the PileUp method with GrowTree (Genetics Computer Group).
Results
Patient details
The clinical details of the eight patients in this study are summarised in Table 1 . The male:female ratio was 1:1. The median age was 64 (range 51-82) years. All eight patients had underlying disease, including liver cirrhosis in five (cases 1, 2, 4, 6 and 7), chronic renal failure in one (case 5), diabetes mellitus in two (cases 3 and 7), intravenous drug abuse in one (case 4) and lymphoma in one (case 2). Six patients had fever or chills on admission (cases 1, 2, 3, 6, 7 and 8), whereas three had abdominal pain (cases 3, 5 and 6) and two had diarrhoea (cases 5 and 8). Two patients had cellulitis (cases 4 and 6). Six patients had neutrophilia (cases 1, 2, 4, 5, 6 and 8) and all had lymphopenia. All eight isolates were isolated from the blood cultures taken from the patients on the day of admission. Two of the eight patients died despite antibiotic treatment (cases 1 and 5).
Phenotypic characteristics of the bacterial isolates
All eight blood culture isolates exhibited the same phenotypic characteristics. They grew on blood agar, chocolate agar and MacConkey agar as grey, flat, irregular colonies of 2 mm diameter after incubation for 48 h at 378C in micro-aerobic conditions. They 
ND, not determined; V, variable; W, weakly positive; R, resistant; S, sensitive. THERMO-TOLERANT CAMPYLOBACTER FETUS BACTERAEMIA grew poorly in air with CO 2 5% at ambient temperature. Microscopic examination of the isolates revealed them all to be gram-negative, slender, curved, seagullshaped, motile bacilli. They were cytochrome oxidase positive but were unable to metabolise glucose or produce acid from it. They were sensitive to polymyxin B, and negative for arylsulphatase and pyrazinamidase. Thus, they were typical members of the genus Campylobacter. The results of further phenotypic tests to distinguish between the blood culture Campylobacter isolates and the known Campylobacter spp. are summarised in Table 2 . All eight blood culture Campylobacter isolates were able to grow at 258C, 378C and 428C and in the presence of glycine 1%, but not in the presence of NaCl 1.5% or 3.5%. They were catalase positive, reduced nitrate but not nitrite, did not hydrolyse hippurate or indoxyl acetate, did not produce H 2 S or alkaline phosphatase, and were resistant to nalidixic acid but sensitive to cephalothin. The MICs (mg=L) of ampicillin, clarithromycin, gentamicin, ciprofloxacin and imipenem for the eight isolates were 1-4, 1-4, 0.5-1, 0.25-.32 and 0.015-0.03, respectively (Table 3) .
16S rRNA gene sequencing PCR of the 16S rRNA genes of the blood culture Campylobacter isolates showed bands at 1449 bp. Sequencing of the 16S rRNA genes showed that all eight isolates had the same nucleotide sequence. There were 11 base differences between those of the isolates and C. fetus subsp. fetus (GenBank accession no. M65012), 9 base differences between those of the isolates and C. fetus subsp. venerealis (GenBank accession no. M65011), 16 base differences between those of the isolates and C. fetus (GenBank accession no. AF219234), but no base differences between those of the isolates and C. fetus (GenBank accession no. AF219233), indicating that the isolates were C. fetus (Fig. 1) .
Discussion
16S rRNA gene sequencing was used to show that all eight blood culture isolates of Campylobacter spp. from eight immunocompromised patients were C. fetus.
All eight isolates grew at 428C, but poorly at 258C, and did not produce H 2 S. Because only a small percentage of C. fetus grow at both 258C and 428C, phenotypic tests alone were unable to determine whether the isolates were those of a thermo-tolerant C. fetus, or an H 2 S-negative C. hyointestinalis, or a new species of Campylobacter.
The data from the present study suggest that these thermo-tolerant C. fetus isolates from patients in this locality cause a febrile bacteraemic illness similar to that caused by other C. fetus isolates. The median age of the eight patients was 64 years, which is similar to the mean age of 54.1 years reported in a previous study [34] . In three published studies, C. fetus bacteraemia was associated with underlying diseases in 41%, 75% and 75% of the patients, respectively [34] [35] [36] . In the present study, all eight patients with thermo-tolerant C. fetus bacteraemia had major underlying diseases. Similar to previous reports, these patients presented with a febrile illness with or without gastrointestinal symptoms such as diarrhoea and abdominal pain. The association of C. fetus bacteraemia with vascular pathology and cellulitis has been well documented [34] [35] [36] and was also present in two of the patients in the present study, who had right thigh and leg cellulitis, respectively. Similar to a previous report [35] in which 25% of the patients with C. fetus died, the patients in the present study also had significant mortality.
The ability of thermo-tolerant C. fetus to grow over a wide range of temperatures can have direct implications for both its natural reservoir and the incidence of bacteraemia. Most Campylobacter spp. are adapted to the intestines of warm-blooded animals. Because of their ability to grow at 428C, C. jejuni and C. lari strains are particularly adapted to birds, which are probably the major reservoir of these organisms. On the other hand, as most C. fetus subsp. fetus and all C. fetus subsp. venerealis are unable to grow at 428C, they are less commonly found in birds. The main reservoirs for these two species are cattle and sheep. Because thermo-tolerant C. fetus isolates can grow at 258C, 378C and 428C, they may be able to adapt to growth not only in cattle and sheep, but also in birds. In a national survey in the UK for 1981-1991, C. jejuni accounted for 80% but C. fetus for only 9% of the Campylobacter bacteraemic isolates [34] . It has been suggested that the rarity of C. fetus bacteraemia is due to its predilection for growth at 258C. In this study and contrary to the previous report, thermo-tolerant C. fetus was the predominant Campylobacter sp. causing bacteraemia. It accounted for 53% of the Campylobacter bacteraemia in the period 1996-2000, whereas C. jejuni subsp. jejuni, C. coli and C. lari accounted for only 33% (five cases), 7% (one) and 7% (one) of the Campylobacter bacteraemias, respectively. This predominance of C. fetus in causing bacteraemia in the study locality may be due to the ability of thermo- Campylobacter fetus (AF219233)
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Campylobacter sputorum (AF022768) Fig. 1 . Phylogenetic tree showing the relationship of the eight C. fetus isolates to other Campylobacter spp. The tree was inferred from 16S rRNA sequence data by the neighbour-joining method. The scale bar indicates the estimated number of substitutions per 100 bases using the Jukes-Cantor correction. Names and accession nos are given as cited in the GenBank database.
tolerant isolates to grow at a wider range of temperatures. As a result of this tolerance to a wider range of temperatures, leading to a possible wider range of natural hosts as well as a high incidence of bacteraemia in the past 5 years, thermo-tolerant C. fetus may be an emerging pathogen in immunocompromised patients in the years to come.
